Therefore, these evidences enlighten us to make a hypothesis that EF24 might interrupt the process of hepatocarcinogenesis through down-regulate the NF-κB pathway and further to be an agent of special therapeutic effect for hepatitis caused HCC. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.